Business Description
ORIC Pharmaceuticals is a US-based drug development company focused on finding new ways to stop cancer cells from becoming resistant to treatment. Its two lead compounds are currently being tested in early-stage clinical trials ? one targeting specific mutations linked to lung and other cancers, and another aimed at prostate cancer in partnership with major pharmaceutical companies including Bayer and Johnson & Johnson. Founded in 2014 and based in South San Francisco, California, ORIC is working to improve outcomes for patients whose cancers have stopped responding to existing therapies.
